click on the link below To view or add a comment, sign in We analysed cholesterol data from thousands of Thriva users
For some patients, neuro-regulating peptides become a useful tool inside this broader plan
The first one released was Semaglutide (Ozempic), and diabetics lost weight during clinical studies, explaining why this drug was immediately re-purposed
This movement emphasizes that obesity should not be viewed as a pathology requiring a cure (Holi, 2025), nor as an epidemic necessitating personal responsibility for its resolution (Gailey, 2022)
Duration of Treatment Studies have evaluated Retatrutide for up to 48 weeks, but real-world use might extend longer
However, large-scale, multi-center studies are needed to confirm its diagnostic value